COLORADO SPRINGS, Colo. & SEATTLE–(BUSINESS WIRE)–InnoVero, a global leader in providing innovative, athlete-centric collection technologies to anti-doping organizations worldwide and Tasso, Inc., the leading provider of patient-centric, clinical grade blood collection solutions, today announced the extension of their partnership that was first initiated in 2021. In addition to collaboratively developing new athlete-centric solutions, InnoVero will continue to serve as the exclusive worldwide
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
